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Glycoalkaloids are the biologically active secondary metabolites found in many plants, such as potatoes. Glycoalkaloids are produced in leaves, roots, tubers and sprouts of the potato plant, and are involved in host plant resistance to bacteria, fungi, viruses, and insects. 1) Several reports have showed that glycoalkaloids suppress the growth of cancer cells in human skin, liver, prostate, breast and colon. [2] [3] [4] aChaconine, a trisaccharide glycoalkaloid, is the main steroidal glycoalkaloid in potato (Solanum tuberosum). 1) Recent studies demonstrated that a-chaconine inhibited the growth of human colon (HT29), liver (HepG2), cervical (HeLa), lymphoma (U937), and stomach (AGS and KATO III) cancer cells. 3, 5) a-Chaconine also induced apoptosis of human colon cancer cells through the inhibition of extracellular signal regulating kinase (ERK) phosphorylation and activation of caspase-3. 6) In addition, a-chaconine inhibited migration and invasion of human lung adenocarcinoma A549 cells by reducing matrix metalloproteinase (MMP)-2 and MMP-9 activities through the suppression of phosphatidylinositide-3 kinase/ Akt/nuclear factor kappa B (PI3K/Akt/NF-kB) signaling pathway. 7) Therefore, a-chaconine may possess the potential for cancer chemotherapeutic action.
Angiogenesis, a process of new blood vessel formation from a pre-existing microvascular network, plays important roles in many physiological functions including wound healing, embryonic development, and the normal menstrual cycle. Angiogenesis is also involved in pathological conditions, such as ischemia, atherosclerosis, arthritis and carcinogenesis. 8) During tumor development, newly generated vessels are necessary for supplying sufficient oxygen and nutrients to the growing tumor mass, and facilitating the metastatic spreading. 8, 9) The process of angiogenesis includes proliferation, migration, invasion, as well as tube formation of endothelial cells. The process of angiogenesis is promoted by expressing and secreting various proteases that can degrade most extracellular matrix (ECM) components. 10) MMPs, a family of Zn-dependent endopeptidases, are the major proteases in angiogenesis and are closely correlated with invasive and metastatic potentials of cancer cells. 11) Several MMPs, such as MMP-2 and MT1-MMP, are produced by endothelial cells and contribute to the process of angiogenesis. 12) As well as MMPs, the mitogen-activated protein kinases family members (MAPK) are also known to mediate angiogenesis. MAPK family members participate in numerous signaling cascades that play important regulatory roles in cell growth, apoptosis, differentiation, and angiogenesis. The diverse MAPK members are activated in response to various extracellular stimuli and have distinct downstream targets, thus stimulating endothelial cell proliferation and protease production, and acting as positive mediators of angiogenesis. [13] [14] [15] Angiogenesis is also regulated by PI3K/Akt signaling pathway, which has been implicated in a number of cellular functions including cell survival, cell adhesion and metastasis. 16, 17) Moreover, PI3K/Akt and MAPK signaling pathways play a central role in regulating the expression of MMPs by transcriptional factors, including NF-kB. 13, 15, 18) The active NF-kB consists of a dimer of a REL family/p65 subunit and a p50 or p52 subunit. NF-kB is maintained in the cytoplasm in an inactive form, bound by inhibitory pro- Although a-chaconine exhibits anti-carcinogenic potential against several cancer cell lines, its effect on angiogenesis is still unclear. The objective of this work was to examine the inhibitory effects and molecular mechanisms of a-chaconine on angiogenesis in vitro.
MATERIALS AND METHODS
Reagents and Antibodies a-Chaconine, dimethyl sulfoxide (DMSO), Tris-HCl, ethylenediaminetetraacetic acid (EDTA), sodium dodecyl sulfate (SDS), phenylmethylsulfonyl fluoride (PMSF), leupeptin, Nonidet P-40, deoxycholic acid, sodium orthovanadate, SP600125, LY294002 and pyrrolidine dithiocarbamate (PDTC) were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.). Protein assay kit was obtained from Bio-Rad Labs (Hercules, CA, U.S.A.). Powdered Dulbecco's modified Eagle's medium (DMEM) were purchased from Gibco/BRL (Gaithersburg, MD, U.S.A.). Matrigel was from BD Biosciences (Bedford, MA, U.S.A.). Total RNA extraction kit and polymerase chain reaction (PCR) kit were from Viogene (Sunnyvale, CA, U.S.A.). Antibodies against ERK, JNK, p38, Akt, NF-kB (p65), IkBa, C23 and phosphorylated proteins were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Antibodies against PI3K and phosphorylated PI3K were purchased from Cell Signaling Technology (Danvers, MA, U.S.A.).
Cell Culture Bovine aortic endothelial cells (BAECs) were obtained from BCRC (Food Industry Research and Development Institute, Taiwan). Cells were cultured in DMEM supplemented with 10% fetal calf serum, 100 U/ml of penicillin and 100 mg/ml streptomycin. Cells were incubated in a humidified incubator at 37°C and 5% CO 2 . For a-chaconine treatment, the stock solution of a-chaconine was dissolved in DMSO and diluted with culture medium (final concentration of DMSO was less than 0.2%).
Cell Viability Assay The assay was performed as described previously. 21) Briefly, 4ϫ10 3 cells/well were seeded in a 96-well plate for 24 h. The cells were then treated with a-chaconine at various concentrations for 24 and 48 h. At the end of incubation, the medium was replaced with fresh medium containing 0.5 mg/ml MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]. After 4 h, the supernatants were removed and the resulting MTT formazan was solubilized in DMSO and measured spectrophotometrically at 570 nm.
Wound Healing Migration Assay The assay was performed as described with modification. 22 Chemotaxis and Invasion Assays Chemotaxis and invasion assays were carried out in Boyden chambers as previously described with modification. 18) Briefly, the 8-mm pore polycarbonate filter was coated with type-I collagen (10 mg/ml) or Matrigel for chemotaxis and invasion assay, respectively. BAECs were added to the upper chamber with a density of 2ϫ10 4 cells/well in serum-free medium containing various concentrations of a-chaconine. Medium containing 10% fetal bovin serum (FBS) and corresponding doses of achaconine were applied to the lower chamber as chemoattractant. The chamber was incubated for 6 h at 37°C. At the end of incubation, the cells in the upper surface of the membrane were carefully removed with a cotton swab and cells that invaded to the lower surface of the membrane were fixed with methanol and stained with 5% Giemsa solution. The invaded cells on the lower surface of the membrane filter were counted using a light microscope.
Tube Formation Determination The tube formation assay was performed as described with modification.
23) A 15-well m-Slides (ibidi, Germany) was coated with 10 ml of Matrigel which was allowed to solidify at 37°C for 1 h. 8ϫ10 3 cells were seeded on the Matrigel and cultured in DMEM medium containing different concentrations of a-chaconine or 0.1% DMSO for 6 h. The enclosed networks of complete tubes were counted and photographed under an inverted microscope. The tubular lengths of the cells were measured using the program Image J.
RNA Extraction and Reverse Transcription PCR Extraction of total BAEC RNA was performed using total RNA extraction kit. Total RNA (1 mg) from each sample was subject to reverse transcription with oligo(dT) primers by PCR kit according to manufacturer's instruction. The synthesized cDNA was used for PCR amplification using the following primers: MMP-2, 5Ј-gtggcaaccccgacgtgg-3Ј (For), 5Ј-gcagggctgtccgtcgg-3Ј (Rev); HPRT (Hypoxanthine-guanine phosophoribosyltransferase): 5Ј-tcctgcaccaccaactgctt-3Ј (For), 5Ј-tgcttcaccaccttcttgat-3Ј (Rev). cDNAs were amplified for 30 cycles and each PCR reaction condition was as follows: preparation step at 94°C for 5 min, denaturing step at 94°C for 30 s, annealing step at 57°C for 30 s, and polymerization step at 72°C for 30 s. PCR products were analyzed by agarose gel electrophoresis.
Analysis of MMP-2 Activity by Gelatin Zymography
The activity of MMP-2 was assayed by gelatin zymography as described previously. 24) Briefly, subconfluent BAECs were incubated with serum-free medium in the presence of various concentrations of a-chaconine for 24 h. The conditioned medium was then collected and the sample (20 mg) was mixed with loading buffer and subjected to 10% SDS-polyacrylamide gel containing 0.1% gelatin. Electrophoresis was performed at 100 V for 3 h at 4°C. Gels were then washed with washing buffer (2.5% Triton X-100 in dd H 2 O) at room temperature to remove SDS, followed by incubation at 37°C in reaction buffer (40 mM Tris-HCl, pH 8.0, 10 mM CaCl 2 , 0.02% NaN 3 ). After 16 h, the gels were stained with Coomassie blue R-250 (0.125% Coomassie blue R-250, 50% methanol, 10% acetic acid) for 1 h and destained with destaining solution (20% methanol, 10% acetic acid, 70% ddH 2 O) until the clear bands were visualized.
Nuclear Protein Extraction The nuclear proteins were prepared as previously described with modification. 7) Briefly, cells were washed with ice-cold PBS, then resuspended in cold PBS and centrifuged for 1 min at 3000 rpm at 4°C. The pellet was resuspended in hypotonic buffer (10 mM N-(2-hydroxyethyl)piperazine-NЈ-2-ethanesulfonic acid (HEPES), pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.05% NP-40, 0.5 mM dithiothreitol (DTT) and 0.5 mM PMSF) and left on ice for 10 min. The nuclei were centrifuged for 10 min at 3000 rpm at 4°C, and the supernatant was collected as cytosolic extract. The pellet was then resuspended in nuclear extract buffer (20 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 420 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF and 25% glycerol) and incubated for 30 min on ice. After another centrifugation at 14000 rpm for 10 min, the supernatant containing the nuclear protein was transferred into a prechilled microcentrifuge tube. The extracts were stored at Ϫ80°C.
Western Blotting Analysis After being treated with achaconine, BAECs were washed twice with PBS and treated with extraction buffer (50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 0.1% SDS, 1% NP-40, and 0.5% deoxycholic acid). The cell extractions were collected and centrifuged at 10000ϫg for 10 min at 4°C, and the supernatants were collected as cell lysates. The cell lysates were subjected to SDS-polyacrylamide gel electrophoresis (PAGE), and transferred to nitrocellulose membranes (Millipore, Bedford, MA, U.S.A.). The membrane was blocked with 5% (w/v) non-fat milk in PBS containing 0.1% Tween-20, and then blotted with primary antibody. Subsequently, the membranes were incubated with appropriate secondary antibody (horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit immunoglobulin G (IgG)), the immuno-detected proteins were revealed by enhanced chemiluminescence.
Statistical Analysis Data were expressed as meanϮstan-dard deviation. Statistical significance was analyzed by oneway ANOVA. If the significance was observed, the Dunnett's post-hoc test was used to determine the difference of treatment groups and untreated group, with values of pϽ0.05 considered statistically significant.
RESULTS

Cytotoxic Effect of a a-Chaconine in BAECs
We first elucidated the cytotoxic effect of a-chaconine on BAECs. The cell viabilities in the presence of various concentrations of a-chaconine were analyzed by MTT assay. As shown in Fig. 1 , the treatment of a-chaconine with 4 mg/ml for 24 h or 48 h decreased cell viabilities significantly. However, cell viabilities were not significantly changed by a-chaconine at concentration below 3 mg/ml. These results indicated that treatment with a-chaconine at doses of no more than 3 mg/ml for 24 h and 48 h did not cause cytotoxicity.
a a-Chaconine Inhibits Migration in BAECs To investigate the inhibitory effect of a-chaconine on migration of BAECs, the in vitro wound healing assay was performed.
The confluent monolayer was scraped by a sterile micropipette tip for creating a scratch wound. After incubation with various concentrations of a-chaconine for 9 h, the cells migrated to the denuded zone and the level of wound closure area was analyzed. The results demonstrated that a-chaconine suppressed migration of BAECs to the denuded zone in a dose-dependent manner (Fig. 2) . Treatment with a-chaconine of 3 and 4 mg/ml inhibited 19.3% and 30.2% of cell migration, respectively. These results revealed that a-chaconine inhibited the motility of BAECs significantly.
a a-Chaconine Inhibits Chemotaxis and Invasion in BAECs To elucidate the inhibitory effect of a-chaconine on BAEC chemotaxis and invasion across the extracellular matrix, the cells that invaded through type-I collagen-and Matrigel-coated polycarbonate filter in Boyden chamber were analyzed. The results showed that a-chaconine suppressed chemotaxis of BAECs in a dose-dependent manner. Treatment with a-chaconine of 2 and 3 mg/ml inhibited 49.8% and 96.6% of cell chemotaxis, respectively (Fig. 3A) . a-Chaconine also dose-dependently abolished the invasion of BAECs across the Matrigel-coated filter. Treatment at doses of 1 and 2 mg/ml inhibited 56.9% and 84.6% of cell invasion, respectively (Fig. 3B) . The results indicated that achaconine markedly inhibited chemotaxis and invasion of BAECs.
a a-Chaconine Inhibits Tube Formation in BAECs The tube formation assay of endothelial cells that mimics the angiogenic process was used to determine the anti-angiogenic activities of a-chaconine. BAECs incubated on Matrigel substratum for 6 h resulted in the formation of elongated and tube-like structure in the control group, whereas BAECs exposed to a-chaconine formed incomplete and sparse tube networks (Fig. 4A) . a-Chaconine at concentrations of 2, and 3 mg/ml reduced tube formation by 37.4% and 58.9%, respectively (Fig. 4B) .
a a-Chaconine Inhibits Activation and Expression of MMP-2 in BAECs Since the expression of MMPs is crucial for ECM degradation, which is required for angiogenesis, the effect of a-chaconine on the activation of MMPs was investigated. After BAECs were treated with various concentrations of a-chaconine for 24 h in serum-free medium, the conditioned medium was collected and assayed for MMP activity by gelatin zymography. Results showed that MMP-2 activity was markedly reduced by treatment with a-chaconine of 3 mg/ml for 24 h (Fig. 5A) . We further demonstrated 
Fig. 3. Effect of a-Chaconine on Chemotaxis and Invasion of BAECs
The chemotaxis and invasion of BAECs was measured by Boyden chamber with 10 mg/ml type-I collagen-or Matrigel-coated polycarbonate filters (pore size, 8 mm) in the presence of a-chaconine for 6 h. After incubation, the cells that invaded into the lower surface of the polycarbonate filters were fixed, stained and visualized under microscopy (200ϫ magnification). The invaded cells across type-I collagen-coated (A) or Matrigel-coated (B) filters were counted in five random fields in each treatment, and data were calculated from three independent experiments. Data are presented as meanϮS.D. * * pϽ0.01, * * * pϽ0.001, compared with the untreated control.
that a-chaconine suppressed the expression of MMP2 mRNA and protein determined by reverse-transcription (RT)-PCR and Western blotting, respectively (Figs. 5B, C) . The results showed that both enzyme activity and expression of MMP-2 were inhibited by a-chaconine. a a-Chaconine Inhibits Phosphorylation of JNK, PI3K and Akt Several studies have indicated that signaling proteins MAPK members, PI3K and Akt are involved in the expression of MMP-2 and inducing angiogenesis. 13, 14, 25) In order to evaluate whether a-chaconine mediates and/or inhibits the activities of MAPK members, PI3K and Akt, the effects of a-chaconine on the phosphorylated status of ERK1/2, JNK1/2, p38 MAPK, PI3K and Akt in BAECs were investigated. Data demonstrated that a-chaconine reduced the phosphorylation of JNK1/2, while it did not alter the phosphorylation of ERK1/2, and p38 MAPK (Figs. 6A, B) . The quantitative results showed that a-chaconine significantly suppressed the phosphorylation of JNK1/2 in a doseand time-dependent manner (Fig. 6D) . In contrast, a-chaconine did not significantly decreased the expression of phospho-ERK1/2 and phospho-p38 levels (Figs. 6C, E) . In addition, we demonstrated that a-chaconine suppressed the phosphorylation of PI3K and Akt (Figs. 7A, B) . The quantitative results showed that a-chaconine inhibited the phosphorylation of PI3K and Akt in a dose-and time-dependent manner (Figs. 7C, D) . (A) BAECs were treated with various concentrations of a-chaconine for 24 h and the conditioned media were collected. The MMP-2 activity was determined by gelatin zymography. After treatment with a-chaconine for 24 h, the expression of MMP-2 mRNA (B) and protein (C) was analyzed by RT-PCR and Western blotting, respectively. HPRT or b-actin was used as an internal control. C: control; D: 0.2% DMSO as solvent control. MMP-2 activity, mRNA and protein levels were quantified by densitometric analysis. The densitometric data were expressed as meanϮS.D. of three independent experiments. * pϽ0.05, * * pϽ0.01 compared with the untreated control.
effect of a-chaconine on the activity of NF-kB, the amount of IkBa in the cytosolic extracts and NF-kB in the cell nuclear extracts were measured by Western blotting. Data revealed that a-chaconine-treated BAECs demonstrated an increase in the cytosolic protein level of IkBa (Fig. 8A) and a decrease in the nuclear protein level of NF-kB (Fig. 8B) . The results implicated that a-chaconine significantly inhibited NF-kB activity.
To further investigate whether the inhibition of a-chaconine on tube formation was through inhibition of the JNK1/2, PI3K and NF-kB signaling pathways, BAECs were pretreated with a JNK inhibitor (SP600125; 20 mM), PI3K inhibitor (LY294002; 5 mM) and NF-kB inhibitor (PDTC; 20 mM) for 30 min and then incubated in the presence or absence of a-chaconine (2 mg/ml) for 6 h. Results showed that a sole treatment of SP600125, LY294002, and PDTC, reduced tube formation by 63.8%, 39.8%, and 45.4%, respectively. The combination treatment of a-chaconine enhanced the inhibitory effect of these inhibitors on tube formation (Fig. 9) . The results revealed that the inhibition of tube formation by achaconine could partly occur through suppressing JNK1/2, PI3K and NF-kB pathways. DISCUSSION a-Chaconine and a-solanine are the main glycoalkaloids in potatoes. These glycoalkaloids present in potatoes are relatively stable, and are not destroyed by baking, frying, microwaving, or drying at high temperatures. 26) Since glycoalkaloid-containing potatoes and potato products are widely consumed, the toxic effects of these potato glycoalkaloids must be clarified. a-Chaconine, one of the major glycoalkaloids in potato, has been shown to exhibit toxicity in developing frog embryos, 27) in livers of mice, 28) and in normal human liver cells.
3) In addition to the toxic effects in normal physiological functions, recent studies demonstrated that a-chaconine revealed anti-carcinogenic potentials, such as inhibiting cell growth of various cancer cell lines, inducing apoptosis of human colon cancer cells, 3, 5, 6) as well as suppressing human lung cancer cell migration and invasion through reducing MMP-2/9 activities. 7) Although a-chaconine is toxic to normal physiology, the compound possesses potential for therapeutic treatment against cancer cells. Tumor angiogenesis is necessary for tumor growth and metastasis, so we attempted to investigate the effect of a-chaconine on suppressing angiogenesis. In the present study, we provided evidences that a-chaconine was able to inhibit angiogenesis in vitro, such as proliferation, migration, invasion and tube formation in endothelial cells, suggesting that a-chaconine might possess anti-angiogenic potential.
Proliferation, migration, invasion and tube formation in endothelial cells are the major steps of angiogenesis. We demonstrated that a-chaconine suppressed proliferation of BAECs significantly at the concentration of 4 mg/ml. When BAECs were treated with a-chaconine at non-toxic doses (below 3 mg/ml), the chemotatic mobility, invasion and tube formation in cells were inhibited. These results implied that the inhibitory effects of a-chaconine on endothelial cell chemotatic mobility, invasion and tube formation were not due to its cytotoxic effect.
The proteolytic degradation of ECM mediated by extracellular proteases, such as MMPs, is required for endothelial cell migration and invasion at the start of angiogenesis. MMP activity is also associated with potential of endothelial cells to sprout and invade within a 3D extracellular matrix. 29) Thus, we investigated the effect of a-chaconine on MMPs. MMPs are a family of zinc-containing endopeptidases, and of these, MMP-2 (gelatinase A, 72 kDa collagenase type IV) plays a crucial role in angiogenesis. 30, 31) It has also been shown that tumor angiogenesis is reduced in MMP-2 deficient mice. 32) Therefore, we focused on the effect of a-chaconine on MMP-2 activity. Our data showed that treatment with a-chaconine of 3 mg/ml for 24 h diminished the expression and activity of MMP-2 significantly. These results suggested that the inhibition of MMP-2-mediated enzymatically degradative process might be attributed to the anti-invasion effect of a-chaconine. The inhibitory effect of a-chaconine on MMP-2 may be, at least in part, responsible for its antiangiogenic potential.
MMP-2 activity is regulated by its gene expression and proenzymatic activation. Our RT-PCR and Western blotting data revealed that a-chaconine reduced MMP-2 mRNA and protein expression respectively, so we attempted to investigate the mechanism related to the event. Numerous reports have demonstrated that MMP-2 expression is critically mediated by MAPK members 13, 15) and PI3K/Akt pathway. 23, 33, 34) MAPK and PI3K/Akt pathways also play an important role in endothelial cell viability, migration, and tube formation by specific stimuli. [13] [14] [15] 25, 35, 36) Therefore, we examined the effect of a-chaconine on the activities of MAPK and PI3K/Akt signaling pathways. Results demonstrated that treatment with a-chaconine inhibited JNK, PI3K and Akt phosphorylation significantly, suggesting that the signaling pathways mediated by JNK and PI3K/Akt were suppressed by a-chaconine. Consistent with our findings, several reports have indicated that inhibition of JNK decreased proliferation, migration and sprouting within a 3D ECM in endothelial cells. 13, 29, 37, 38) In addition, suppressing PI3K/Akt pathways resulted in the inhibition of endothelial cells migration, invasion and MMP production. 18, 19) Thus, JNK and PI3K/Akt pathways may be the potential targets for suppressing angiogenesis.
Recent studies has demonstrated that inhibition of NF-kB activity could inhibit angiogenesis. [18] [19] [20] In the present study, we demonstrated that a-chaconine elevated IkBa protein level in the cytoplasm and abolished NF-kB protein level in the nucleus, suggesting a-chaconine treatment resulted in NF-kB binding with IkBa in the cytoplasm in an inactive form. Hence, the inhibitory effect of a-chaconine on NF-kB may be involved in the antiangiogenic mechanisms of a-chaconine.
The present results demonstrated that a-chaconine inhibited phosphorylation of JNK, PI3K, Akt and activation of NF-kB was observed after 12 h and 24 h incubations, respectively. However, a-chaconine reduced BAECs migration, chemotaxis, invasion, and tube formation at 6 or 9 h after incubation. Thus, the inhibitory effect of a-chaconine seems not via directly interfering phosphorylation of JNK, PI3K, or activation of NF-kB. In addition, we showed that inhibiors of JNK, PI3K and NF-kB inhibited BAEC tube formation significantly, and a-chaconine could enhance the inhibitory effects of these inhibitors on BAECs tube formation. According to the results, we suggested that a-chaconine inhibited BAECs functions associated with angiogenesis might partly through JNK, PI3K, and NF-kB pathways.
In conclusion, we attributed the decrease in expression and activity of MMP-2 by a-chaconine to the inactivation of the JNK and PI3K/Akt signaling pathways and NF-kB activity, and such inhibitory effect might contribute to the inhibitory effect of a-chaconine on endothelial cell migration, invasion and tube formation. These findings reveal a new therapeutic potential for a-chaconine on anti-angiogenic therapy. BAECs were treated or without a-chaconine; C: control; D: 0.2% DMSO; 1, 2 and 3 mg/ml for 24 h. The cytosolic and nuclear extracts were prepared and analyzed for IkBa degradation (A) and p65 translocation (B). b-actin and C23 were used as a cytosolic and nuclear protein loading control, respectively. Determined activity of NF-kB was subsequently quantified by densitometric analysis. The densitometric results are expressed as meanϮS.D. of three independent experiments. * pϽ0.05, * * pϽ0.01 compared with the untreated control. Fig. 9 . Effect of JNK Inhibitor (SP600125), PI3K Inhibitor (LY294002) and NF-kB Inhibitor (PDTC) on Tube Formation of BAECs Cells were seeded onto Matrigel-coated 15-well m-Slides and pretreated with SP600125 (20 mM), LY294002 (5 mM) or PDTC (20 mM) for 30 min and then incubated in the presence or absence of a-chaconine (2 mg/ml). After 6 h, the enclosed networks of complete tubes were photographed and the tubular lengths of the cells were measured using Image J software. Data are presented as meanϮS.D. of three independent experiments. * * pϽ0.01, compared with the untreated control.
